SCHEMBL9366136

SCHEMBL9366136

C1=CCN(C(Cc2ccccc2)c2ccccc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 14/20 0.62
SLC6A2 P23975 9/20 0.62
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2D6 P10635 1/20 0.61
TSHR P16473 1/20 0.61
CYP2C19 P33261 1/20 0.61
OPRM1 P35372 1/20 0.55
OPRD1 P41143 1/20 0.55
OPRK1 P41145 1/20 0.55
OPRL1 P41146 1/20 0.55
SLC6A3 Q01959 2/20 0.48
MAOA P21397 2/20 0.45
HRH3 Q9Y5N1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8658938 0.84 MAOA (0.47) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL8073787 0.82 OPRL1 (0.55) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL8073783 0.82 OPRL1 (0.55) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL9365807 0.80 SLC6A4 (0.40) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL9366741 0.78 CYP1A2 (0.96) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL6171525 0.77 SLC6A4 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL3715253 0.76 CYP1A2 (1.00) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL9366351 0.73 CYP2D6 (0.70) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL8445058 0.73 CYP2D6 (0.62) CYP1A2CYP3A4CYP2D6CYP2C19OPRM1
SCHEMBL14722649 0.72 CYP1A2 (0.68) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0346791-B1 1,2-diarylethylamines for treatment of neurotoxic injury SEARLE & CO (US) 1994-04-06 EP claimed
EP-0346791-A1 1,2-diarylethylamines for treatment of neurotoxic injury G.D. Searle & Co. (US) 1989-12-20 EP claimed
EP-0346791-B1 1,2-diarylethylamines for treatment of neurotoxic injury SEARLE & CO (US) 1994-04-06 EP disclosed
EP-0346791-A1 1,2-diarylethylamines for treatment of neurotoxic injury G.D. Searle & Co. (US) 1989-12-20 EP disclosed